Literature DB >> 7682015

Deficiencies in school readiness skills of children with sickle cell anemia: a preliminary report.

C Chua-Lim1, R B Moore, G McCleary, A Shah, V N Mankad.   

Abstract

Patients with sickle cell anemia often express myriad clinical signs and symptoms that affect their life-style and academic performance. Certain psychoeducational and psychosocial factors have been shown to influence the academic achievement of older patients with sickle cell anemia. However, studies evaluating the school readiness skills of younger children have not been published. To determine whether sickle cell anemia delays preschool development in children aged 4 to 6 years, we studied 10 affected children and 10 normal subjects matched for age, sex, and race. School readiness was evaluated by the Pediatric Examination of Educational Readiness (PEER), which assess a child's performance in areas of developmental attainment such as visual input, verbal output, and short-term memory. The presence of associated movements (minor neurologic signs) and other areas of behavior such as selective attention, activity level, adaptive behavior, and processing efficiency are also observed. The children with sickle cell anemia scored significantly lower than their normal counterparts in several parameters of the PEER. The McCarthy Scales of Children's Abilities, a standardized psychometric test, showed that these children with sickle cell anemia were within the normal range of intelligence. Magnetic resonance imaging done on three children with sickle cell anemia who scored lowest on the PEER revealed no cerebrovascular infarcts. These preliminary studies demonstrate significant differences in school readiness skills between children with sickle cell anemia and normal subjects.

Entities:  

Mesh:

Year:  1993        PMID: 7682015     DOI: 10.1097/00007611-199304000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  A comparative study of academic achievement of children with sickle cell anemia and their healthy siblings.

Authors:  Olusoga B Ogunfowora; Durotoye M Olanrewaju; Gregory I Akenzua
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

2.  Developmental Screening in Pediatric Sickle Cell Disease: Disease-Related Risk and Screening Outcomes in 4 Year Olds.

Authors:  Jeffrey Schatz; Alyssa Schlenz; Laura Reinman; Kelsey Smith; Carla W Roberts
Journal:  J Dev Behav Pediatr       Date:  2017-10       Impact factor: 2.225

3.  Neurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease.

Authors:  Banu Aygun; Jennifer Parker; Molly B Freeman; Alexis L Stephens; Matthew P Smeltzer; Song Wu; Jane S Hankins; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-11-11       Impact factor: 3.167

4.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

5.  The Association between Educational Attainment and Patterns of Emergency Department Utilization among Adults with Sickle Cell Disease.

Authors:  C R Jonassaint; M C Beach; J A Haythornthwaite; S M Bediako; M Diener-West; J J Strouse; S Lanzkron; G Onojobi; C P Carroll; C Haywood
Journal:  Int J Behav Med       Date:  2016-06

6.  Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Authors:  La'Kita M J Knight; Allison A King; John J Strouse; Paula Tanabe
Journal:  J Pediatr Hematol Oncol       Date:  2021-04-01       Impact factor: 1.289

7.  Development and feasibility of a home-based education model for families of children with sickle cell disease.

Authors:  Catherine Hoyt Drazen; Regina Abel; Terianne Lindsey; Allison A King
Journal:  BMC Public Health       Date:  2014-02-05       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.